Login / Signup

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors.

James J Di NicolantonioJorge Barroso-ArandaMark F McCarty
Published in: Open heart (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • drug administration